South African-born biotech entrepreneur and physician Patrick Soon-Shiong has become Los Angeles’ richest man, with an estimated net worth of $8.4 billion (R139.1 billion), according to Business Insider Africa on June 10, 2026. This significant milestone underscores a remarkable journey from a young medical graduate in South Africa to a titan of the North American biotechnology industry.
Soon-Shiong’s ascent to the top of Los Angeles’ wealth hierarchy is a testament to his visionary leadership and strategic acumen in developing groundbreaking medical treatments. His fortune was primarily forged through a series of highly successful biotech ventures, culminating in the development of the revolutionary cancer treatment Abraxane, and subsequent multi-billion dollar exits.
A Journey of Medical Innovation and Entrepreneurial Acumen
Born in Port Elizabeth (now Gqeberha) in 1952, Soon-Shiong’s early life in South Africa was marked by academic brilliance. He completed high school at 16 and graduated from the University of the Witwatersrand at 23. However, professional restrictions as a Chinese doctor, including needing government permission to practice and receiving significantly less pay than some colleagues, prompted his move abroad. He first relocated to Canada and then to the United States, where he established himself as a prominent surgeon and transplant pioneer before transitioning into biotechnology entrepreneurship.
His wealth creation accelerated through companies such as VivoRx, APP Pharmaceuticals, and Abraxis BioScience. The development of Abraxane, a novel cancer treatment, was a pivotal achievement. The strategic sales of APP Pharmaceuticals in 2008 and Abraxis BioScience in 2010 for a combined $9.1 billion cemented his financial standing, positioning him among the world’s wealthiest individuals. Forbes estimates his net worth at $8.4 billion in 2026, solidifying his status as Los Angeles’ richest man.
“Soon-Shiong’s journey exemplifies the global impact of South African entrepreneurial talent, transforming medical science and creating immense wealth abroad.”
Soon-Shiong joins an elite group of South African-born business leaders who have achieved immense global success, including tech luminaries like Elon Musk, Mark Shuttleworth, and Roelof Botha. This trend highlights both the quality of talent originating from South Africa and the opportunities available in more developed global markets.
South Africa’s Enduring Wealth Hub Status
Despite the emigration of some of its most successful individuals and persistent domestic economic challenges such as sluggish growth and power shortages, South Africa remarkably remains Africa’s largest millionaire market. The Africa Wealth Report 2025 indicates that the country is home to 41,100 dollar millionaires, 112 centi-millionaires, and eight billionaires, accounting for 34% of the continent’s total millionaire population. This concentration significantly outpaces Egypt and Nigeria, with Johannesburg and Cape Town serving as Africa’s premier wealth centers.
These cities benefit from deep capital markets, sophisticated financial sectors, and mature investment ecosystems. Although the country’s millionaire population has seen a modest decline of approximately 6% over the past decade, South Africa continues to be a crucial base for entrepreneurs, investors, and business leaders. The robust institutional framework and educational infrastructure within these hubs have historically nurtured talents like Soon-Shiong, providing a strong foundation before their international ventures.
A Continuing Commitment to South Africa’s Future
Unlike some diaspora billionaires who sever operational ties, Patrick Soon-Shiong has maintained a significant engagement in South Africa’s health sector. In 2021, he collaborated with President Cyril Ramaphosa to launch NantSA, an initiative focused on expanding vaccine development and pharmaceutical manufacturing across Africa. This commitment materialized with the opening of a major vaccine manufacturing campus in Cape Town in 2022, specializing in mRNA and T-cell technologies. This project not only aims to bolster local COVID-19 vaccine production but also to strengthen Africa’s broader pharmaceutical manufacturing capabilities.
This initiative underscores a broader significance: South Africa is not merely exporting entrepreneurial talent but is actively attracting biotechnology investment linked to its successful diaspora. Projects involving NantSA, Biovac, and international development finance institutions are positioning the Western Cape as a nascent life-sciences hub on the continent. This fosters the creation of specialized jobs and enhances local pharmaceutical capacity, contributing to a more resilient public health infrastructure.
For investors and policymakers, the narrative of Soon-Shiong and other successful South African expatriates offers a critical lesson. While South Africa possesses a deep pool of entrepreneurial talent and millionaire households, the careers of figures like Soon-Shiong and Musk illustrate how much value creation can occur offshore if local ecosystems do not provide sufficiently competitive opportunities for global scaling. Strengthening these local environments is key to retaining and leveraging such talent for domestic economic growth. To explore more success stories, visit our archives.
